Acute disseminated encephalomyelitis: a follow-up study in Taiwan
- 1 February 2007
- journal article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 78 (2), 162-167
- https://doi.org/10.1136/jnnp.2005.084194
Abstract
Background: Acute-disseminated encephalomyelitis (ADEM) is a demyelinating disorder of the central nervous system, whose epidemiology, clinical presentations and functional outcome are incompletely understood in Asian populations. Objective: To assess the clinical presentations, predisposing factors and functional outcome of ADEM in Taiwan. Methods: 50 patients initially diagnosed with ADEM (male, 19; female, 31) were enrolled from 1991 to 2005. Diagnosis of ADEM or multiple sclerosis was established during a follow-up period of 2–120 months. 8 adult patients were noted to have taken the immunomodulatory drug, levamisole, within 3 months before onset of symptoms. The remaining 42 patients (male, 17; female, 25) were categorised by age as children (<16 years, n = 12), young adults (16–49 years, n = 21) and elderly adults (⩾50 years, n = 9). The clinical manifestations, predisposing factors and radiological findings were compared between different age groups and adult patients with or without levamisole use. Functional outcome was compared by a log-rank test. Results: Preceding upper respiratory tract infection was evident in 21 (50%) patients and only one young-adult patient had received Rubella vaccine immunisation. The frequency of fever was higher in children (p = 0.04) and psychiatric symptoms were more prevalent in elderly patients (p = 0.03). Functional recovery was faster in children than in adults (p = 0.002). Initial Expanded Disability Status Scale score (odds ratio (OR) 1.9, p = 0.03) and no fever (OR 0.04, p = 0.06) were associated with poor outcome (modified Rankin scale ⩾2). After a mean (SD) follow-up of 31.8 (9.9) months, 4 (9.5%) patients developed multiple sclerosis (3 (25%) children, 1 (4.7%) young adult, p = 0.03). The neurological disability, radiological and cerebrospinal fluid findings did not differ between patients with and without levamisole use. One elderly adult patient previously receiving levamisole developed multiple sclerosis of relapse-remitting type after a mean follow-up period of 36.9 months. Conclusion: The clinical presentations, functional outcome and risk of developing multiple sclerosis differed between different age groups. Functional recovery was faster in children than in adults. Poor functional outcome was related to initial high Expanded Disability Status Scale score and absence of fever.Keywords
This publication has 24 references indexed in Scilit:
- First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disabilityThe Journal of Pediatrics, 2004
- Levamisole and Chinese medicinal herbs can modulate the serum interleukin‐6 level in patients with recurrent aphthous ulcerationsJournal of Oral Pathology & Medicine, 2003
- Multiple sclerosis in the Japanese populationThe Lancet Neurology, 2003
- Acute disseminated encephalomyelitisNeurology, 2002
- Clinical and neuroradiologic features of acute disseminated encephalomyelitis in childrenNeurology, 2001
- Acute disseminated encephalomyelitis: A follow-up study of 40 adult patientsNeurology, 2001
- Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in childrenBrain, 2000
- Encephalomyelitis-associated antimyelin autoreactivity induced by streptococcal exotoxinsNeurology, 2000
- Clinical, electrophysiological and magnetic resonance imaging study of acute disseminated encephalomyelitis.1999
- Cerebral Vascular Accidents in Patients over the Age of 60: II. PrognosisScottish Medical Journal, 1957